OMass Therapeutics
Oxford
About OMass Therapeutics
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $162.3M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2023)
- Website: omass.com
- Phone: 01865 548350
Industries & Categories
Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/omass-therapeutics-87293 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.